MCKESSON CORP
MCKNYSETrading Snapshot
- Day Range
- $954.05 – $970.92
- 52-Week Range
- $723.68 – $1,030.27
- Volume (shares)
- 764,081
- Avg Volume (shares)
- —
- Shares Outstanding
- 116.6M
- Next Earnings
- 2026-11-04
Fundamentals Snapshot
- Annual Revenue
- $403.43B
- Last Q Revenue
- $105.38B
- P/E Ratio
- 25.3
- P/S Ratio
- 0.3x
- EPS (TTM)
- $37.35
- Dividend Yield
- 0.34%
- Dilution (1yr)
- −3.6%
MCKESSON CORP
MCK
StockOtter · stockotter.spaceAbout MCKESSON CORP
McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Latest News & Updates
McKesson (MCK) Earnings Expected to Grow: Should You Buy?
McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
McKesson (MCK) Stock Dips While Market Gains: Key Facts
In the most recent trading session, McKesson (MCK) closed at $967.02, indicating a -2.6% shift from the previous trading day.
Here's Why McKesson (MCK) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
McKesson: AI And FDA Overhaul Likely To Overtake Regulatory Drag In 2027
McKesson Corp. stands out as an asset-heavy distributor poised to benefit from AI-driven prescription automation and expedited FDA rare-disease drug approvals. MCK's specialty and oncology segment, with 41% YoY profit gr
McKesson Corporation $MCK Shares Acquired by Carnegie Investment Counsel
Carnegie Investment Counsel raised its position in McKesson Corporation (NYSE: MCK) by 56.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4
Is Trending Stock McKesson Corporation (MCK) a Buy Now?
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.